about
Complete diabetes protection despite delayed thymic tolerance in NOD8.3 TCR transgenic mice due to antigen-induced extrathymic deletion of T cells.Perinatal tolerance to proinsulin is sufficient to prevent autoimmune diabetes.Transient Treg depletion enhances therapeutic anti-cancer vaccination.Analysis of antigen specific T cells in diabetes - Lessons from pre-clinical studies and early clinical trials.Immunotherapy for Lung Malignancies: From Gene Sequencing to Novel Therapies.Functional cytotoxic T lymphocytes against IGRP206-214 predict diabetes in the non-obese diabetic mouse.Granzyme A Deficiency Breaks Immune Tolerance and Promotes Autoimmune Diabetes Through a Type I Interferon-Dependent Pathway.Effector-memory T cells develop in islets and report islet pathology in type 1 diabetes.Combination immune checkpoint blockade as an effective therapy for mesotheliomaTumour associated lymphocytes in the pleural effusions of patients with mesothelioma express high levels of inhibitory receptorsBIM Deficiency Protects NOD Mice From Diabetes by Diverting Thymocytes to Regulatory T CellsTNF receptor 1 deficiency increases regulatory T cell function in nonobese diabetic miceProinflammatory cytokines contribute to development and function of regulatory T cells in type 1 diabetesPre-treatment tumor neo-antigen responses in draining lymph nodes are infrequent but predict checkpoint blockade therapy outcomeSoluble FAS ligand is not required for pancreatic islet inflammation or beta-cell destruction in non-obese diabetic miceNeo-antigen specific T cell responses indicate the presence of metastases before imagingAcquired resistance during adoptive cell therapy by transcriptional silencing of immunogenic antigensImpaired T cell proliferation by ex vivo BET-inhibition impedes adoptive immunotherapy in a murine melanoma model
P50
Q35696624-E1579910-210B-43F7-B917-73BF24C1D2FDQ37277296-3844B655-0380-40F1-A8C9-FAEDB2DEFA87Q37660771-A797F56B-5ABA-41BC-B932-87D97F5405A2Q38809390-30B933A3-C90C-49E1-95C3-1FFAF07CEDC3Q38987879-D2B4489A-BDB1-46E4-9CA1-8BA4B58C6A20Q39201989-F47DA250-0775-48CD-A8D6-DDD8AAC11978Q48364413-5A3A2987-BF0E-412D-8C50-EDC5542709E6Q50868450-BF3A1696-420E-454D-B406-2EA9D8474B3AQ57138329-6976E7A6-9F56-43BA-A7B0-D662FE780364Q59791790-1929D7BD-AE3E-47B1-BE36-9D3F496C6204Q62817614-B196CBFC-5655-465D-95C5-50237D3F5EC0Q84513071-252B55AB-CF2B-4431-95F6-DF2019B7F69DQ85492396-3EA9D79A-A50E-411D-A6C5-FF9788D84D74Q89457621-754DD6F1-5BCC-4451-9893-81618543A972Q90266667-28F2DE49-6E9D-47DD-A933-F1049A63FD07Q90641351-D0B92FC4-892D-4A9A-96B4-E380F6A8D81DQ92628442-F2C00F8D-099E-4CE4-B19A-D10766E8CDC8Q92688922-BB31D3F4-3166-4ABB-94C6-371984E018DE
P50
description
researcher ORCID ID = 0000-0002-7986-2708
@en
wetenschapper
@nl
name
Jonathan Chee
@ast
Jonathan Chee
@en
Jonathan Chee
@es
Jonathan Chee
@nl
type
label
Jonathan Chee
@ast
Jonathan Chee
@en
Jonathan Chee
@es
Jonathan Chee
@nl
prefLabel
Jonathan Chee
@ast
Jonathan Chee
@en
Jonathan Chee
@es
Jonathan Chee
@nl
P1153
53263517200
57193846989
P21
P31
P496
0000-0002-7986-2708